Why Zoetis Inc. (ZTS) Was Downgraded Following Steep Market Selloff?

We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Zoetis Inc. (NYSE:ZTS) is among the most undervalued stocks to invest in.

TheFly reported on May 27 that Argus downgraded ZTS from Buy to Hold following a sharp decline in the company’s share price, including a steep one-day drop of about 22% and continued subsequent weakness. The move reflects growing investor concern over the company’s near-term growth outlook and reduced confidence in its performance trajectory. The analyst noted that recent price action signals a shift in market sentiment, with pressure on the stock driven by deteriorating expectations rather than a single operational event.

In addition to that, earlier on May 7, Zoetis Inc. (NYSE:ZTS) released its financial results for the first quarter of 2026, reporting revenue of $2.3 billion, which reflected a 3% increase compared with the same period in 2025 and was flat on an organic operational basis. Net income totaled $601 million, or $1.42 per diluted share, showing stable performance on a reported basis with 6% per-share growth. Adjusted net income reached $646 million, or $1.53 per diluted share, representing 2% and 9% increases on a reported basis and 1% and 7% growth on an organic operational basis.

Why Zoetis Inc. (ZTS) Was Downgraded Following Steep Market Selloff?

Goodluz/Shutterstock.com

The company noted a more challenging operating environment, including weaker veterinary visits and softer demand in companion animal products, alongside intensified competition. However, livestock and international segments delivered growth across cattle, poultry, swine, diagnostics, and parasiticides, partially offsetting U.S. declines and supporting overall portfolio resilience.

Zoetis Inc. (NYSE:ZTS) is a global animal health company that develops medicines, vaccines, and diagnostics for pets and livestock. Spun off from Pfizer in 2013, it serves veterinarians and farmers worldwide.

While we acknowledge the risk and potential of ZTS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ZTS and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 12 Best Strong Buy Tech Stocks to Invest In Now and 10 Most Widely Held Stocks by Individuals in 2026 .

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1